posted on 2012-11-26, 14:38authored byMark C. Rogers-Evans
A review of the discovery, biological activity and chemical synthesis of
the leukotrienes is presented, together with the latest developments in their
structural modification to produce useful antagonists. Strategies are
presented for the preparation of chiral leukotriene derivatives in which
the characteristic triene unit is replaced by various aromatic groups and
include:
(i) The preparation and attempted separation of the racemic
diastereomers of methyl S-hydroxy-6-(2-methoxycarbonyl-
2-amino-ethylthio>-6-phenylhexanoate; (ii) A chemical synthesis involving the Sharpless asymmetricepoxidation
of (El-ethyl 4-hydroxy-6-phenylhex-S-enoate to (El-ethyl
S( R).6(S)-epoxy-6-phenyl-4(S)-hydroxyhexanoate followed by
selective de-oxygenation studies on the corresponding racemic
epoxy alcohol to give (E}-ethyIS.6-epoxy-6-phenyl-hexanoate; iii An enzymic route utilizing the porcine pancreatic lipase catalysed
hydrolysis of a number of racemic 3-alkyl-3-butanoyloxy-
1.2-epoxides to the corresponding chiral epoxy alcohols with various
degrees of selectivity. one of the most useful being the completely
enantioselective hydrolysis of the less polar diastereomer of·
(E)-3-butanoyloxy-I.2-epoxy-I-phenylhexane. The more
polar diastereomer was preferentially hydrolysed to
l( R),2(S)-epoxy-I-phenylhexan-3-( R)-ol, as verified by
Sharpless epoxidation of (E)-I-phenylhex-I-en-3-01.